Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Antibody Deficiency”

369 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 369 results

Not applicableStudy completedNCT04810559
What this trial is testing

Near Patient Study of the OraQuick ADVANCE® HIV-1/2 Rapid Antibody Test in Oral Fluid and Fingerstick Whole Blood

Who this might be right for
HIV TestingHIV Infections
Unity Health Toronto 600
Testing effectiveness (Phase 2)Looking for participantsNCT06419205
What this trial is testing

Evaluate the Safety, PD, PK, and Clinical Activity of ADX-097 in Participants With IgAN, LN or C3G

Who this might be right for
IgA NephropathyLupus Nephritis (LN)C3 (Complement Component 3) Glomerulopathy
Akebia Therapeutics 30
Testing effectiveness (Phase 2)Study completedNCT03208231
What this trial is testing

Evaluating the Safety and Antiviral Activity of Monoclonal Antibody VRC01 in Infants With HIV Receiving Combination Antiretroviral Therapy

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 61
Large-scale testing (Phase 3)Study completedNCT01458171
What this trial is testing

Follow-up Study of Subcutaneous Immune Globulin in Patients Requiring IgG Replacement Therapy (Japan Study)

Who this might be right for
Primary Immune Deficiency Disorder
CSL Behring 23
Not applicableUnknownNCT01646411
What this trial is testing

300 Antibody Diagnostic Test Kit

Who this might be right for
Acute Bacterial InfectionsAcute Viral Infections
The Plasma Source 300
Large-scale testing (Phase 3)Study completedNCT02810444
What this trial is testing

Study to Investigate Efficacy, Safety and Pharmacokinetics of BT595 in Subjects With PID

Who this might be right for
Primary Immunodeficiency Disease
Biotest 81
Not applicableStudy completedNCT03716700
What this trial is testing

Real-world CANadian CUvitru Non-Interventional Study in Subjects Transitioning From Subcutaneous Immunoglobulin (CANCUN)

Who this might be right for
Primary Immunodeficiency Diseases (PID)
Baxalta now part of Shire 126
Testing effectiveness (Phase 2)Study completedNCT03707977
What this trial is testing

Dual bNAb Treatment in Children

Who this might be right for
HIV Infection
National Institute of Allergy and Infectious Diseases (NIAID) 30
Very early researchWithdrawnNCT03921515
What this trial is testing

Skin Immunity Sample Collection Involving Blisters and Biopsies

Who this might be right for
Hyper-Immunoglobulin E. Syndrome (HEIS)Chronic Granulomatous Disease (CGD)
National Institute of Allergy and Infectious Diseases (NIAID)
Large-scale testing (Phase 3)Study completedNCT03939533
What this trial is testing

Study to Monitor Subcutaneous Human Immunoglobulin Administered at Modified Dosing Regimens in Patients With Primary Immunodeficiency Diseases

Who this might be right for
Primary Immune Deficiency Disorder
Octapharma 64
Early research (Phase 1)Study completedNCT02824536
What this trial is testing

3BNC117 and 10-1074 in HIV Uninfected Adults

Who this might be right for
Human Immunodeficiency Virus
Rockefeller University 24
Testing effectiveness (Phase 2)Study completedNCT00000836
What this trial is testing

A Phase II/III Trial of Human Anti-CMV Monoclonal Antibody MSL 109 (MACRT)

Who this might be right for
Cytomegalovirus RetinitisHIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 300
Testing effectiveness (Phase 2)Active Not RecruitingNCT04556253
What this trial is testing

AK104 in Locally Advanced MSI-H/dMMR Gastric Carcinoma and Colorectal Cancer

Who this might be right for
MSI-H/dMMR Gastric Carcinoma and Colorectal Cancer
Peking University 47
Not applicableNot Yet RecruitingNCT07516002
What this trial is testing

Immunoglobulin Efficacy and Immune Profiling in Antibody Immunodeficiency

Who this might be right for
Primary Immunodeficiency Diseases
Peking University People's Hospital 15
Large-scale testing (Phase 3)Study completedNCT00157079
What this trial is testing

Safety and Efficacy Study of a 10% Intravenous Immune Globulin Solution in Subjects With Primary Immunodeficiency Disorders

Who this might be right for
Primary Immunodeficiency Diseases (PID)Immune Thrombocytopenic Purpura (ITP)Kawasaki Syndrome
Baxalta now part of Shire 61
Post-approval studies (Phase 4)Study completedNCT03033745
What this trial is testing

Safety and Tolerability of Higher Infusion Parameters of IgPro20 (Hizentra) in Subjects With Primary Immunodeficiency (PID)

Who this might be right for
Primary Immunodeficiency
CSL Behring 49
Testing effectiveness (Phase 2)Ended earlyNCT00000961
What this trial is testing

The Safety and Effectiveness of Hyperimmune Anti-HIV Intravenous Immunoglobulin (HVIG) Plus Zidovudine in HIV-Infected Infants

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 112
Early research (Phase 1)Study completedNCT02658968
What this trial is testing

Study of Betalutin for Treatment of Relapsed or Refractory Non-Hodgkin Lymphoma (LYMRIT-37-05)

Who this might be right for
Relapsed, Diffuse Large B-cell LymphomaRefractory Diffuse Large B-Cell Lymphoma
Nordic Nanovector 18
Post-approval studies (Phase 4)Study completedNCT01467947
What this trial is testing

Postmarketing Immunogenicity Study in HAE Subjects Treated With Berinert

Who this might be right for
Hereditary Angioedema Types I and II
CSL Behring 46
Early research (Phase 1)UnknownNCT01937455
What this trial is testing

A Phase 1, Randomized, Blinded, Dose-escalation Study of rAAV1-PG9DP Recombinant AAV Vector Coding for PG9 Antibody in Healthy Male Adults.

Who this might be right for
HIV Infections
International AIDS Vaccine Initiative 21
Next Page